These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29524948)

  • 21. Pharmaceutical policy in China.
    Sun Q; Santoro MA; Meng Q; Liu C; Eggleston K
    Health Aff (Millwood); 2008; 27(4):1042-50. PubMed ID: 18607039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Financial sustainability of the Brazilian Health System and health-related tax expenditures.
    Ocké-Reis CO
    Cien Saude Colet; 2018 Jun; 23(6):2035-2042. PubMed ID: 29972510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug policy in China: pharmaceutical distribution in rural areas.
    Dong H; Bogg L; Rehnberg C; Diwan V
    Soc Sci Med; 1999 Mar; 48(6):777-86. PubMed ID: 10190640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.
    Zhang X; Wu Q; Liu G; Li Y; Gao L; Guo B; Fu W; Hao Y; Cui Y; Huang W; Coyte PC
    BMJ Open; 2014 Dec; 4(12):e006471. PubMed ID: 25534214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health care economics in Serbia: current problems and changes.
    Stosić S; Karanović N
    Vojnosanit Pregl; 2014 Nov; 71(11):1055-61. PubMed ID: 25536810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoliberal science, Chinese style: Making and managing the 'obesity epidemic'.
    Greenhalgh S
    Soc Stud Sci; 2016 Aug; 46(4):485-510. PubMed ID: 28948874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of the Asian health-care market: global implications for the pharmaceutical industry.
    Epstein RJ
    Nat Rev Drug Discov; 2007 Oct; 6(10):785-92. PubMed ID: 17853900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia.
    Tkatchenko-Schmidt E; Atun R; Wall M; Tobi P; Schmidt J; Renton A
    Health Policy Plan; 2010 Jul; 25(4):283-91. PubMed ID: 20144936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Big pharma upheavals cast shadow across biotech sector.
    Ratner M
    Nat Biotechnol; 2012 Feb; 30(2):119-20. PubMed ID: 22318011
    [No Abstract]   [Full Text] [Related]  

  • 30. The Influence of Emerging Markets on the Pharmaceutical Industry.
    Tannoury M; Attieh Z
    Curr Ther Res Clin Exp; 2017; 86():19-22. PubMed ID: 29234483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription Drug Use Among Adults With Chronic Conditions in South Korea: Dual Burden of Health Care Needs and Socioeconomic Vulnerability.
    Jung Y; Byeon J; Chung H
    Asia Pac J Public Health; 2016 Jan; 28(1):39-50. PubMed ID: 26512028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health insurance, assurance, and empowerment in India.
    Bang A
    Lancet; 2015 Dec; 386(10011):2372-3. PubMed ID: 26700517
    [No Abstract]   [Full Text] [Related]  

  • 33. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
    Lipworth W; Doran E; Kerridge I; Day R
    Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil's Unified Health System.
    Bermudez JAZ; Esher A; Osorio-de-Castro CGS; Vasconcelos DMM; Chaves GC; Oliveira MA; Silva RMD; Luiza VL
    Cien Saude Colet; 2018 Jun; 23(6):1937-1949. PubMed ID: 29972501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EACTS in the future: second strategic conference. The view from the BRICS countries.
    Gomes WJ
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):238-40. PubMed ID: 23148073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare systems, the State, and innovation in the pharmaceutical industry.
    Delgado IJ
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00037415. PubMed ID: 27828672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Chinese healthcare system: structure, problems and challenges.
    Hougaard JL; Osterdal LP; Yu Y
    Appl Health Econ Health Policy; 2011; 9(1):1-13. PubMed ID: 21174479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Big Data Research Infrastructure Collaboration Toward the SKA (BRICSKA).
    Taylor R; Porto F; Cui C; Wadadekar Y; Malkov O
    An Acad Bras Cienc; 2021; 93(suppl 1):e20201027. PubMed ID: 34076205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Austerity vs. growth--the impact of the current financial crisis on pharmaceutical innovation.
    Sharma D; Martini LG
    Int J Pharm; 2013 Feb; 443(1-2):242-4. PubMed ID: 23296153
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes mellitus medication use and catastrophic healthcare expenditure among adults aged 50+ years in China and India: results from the WHO study on global AGEing and adult health (SAGE).
    Gwatidzo SD; Stewart Williams J
    BMC Geriatr; 2017 Jan; 17(1):14. PubMed ID: 28077072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.